Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Levy Adam D. | CFO | S Sale | — | $1.57 | $2K | filing |
| Jul 23, 2026 | Miller Mary | GC | S Sale | — | $1.76 | $1K | filing |
ACRIVON THERAPEUTICS (ACRV) insider trading activity (SEC Form 4). Over the trailing 90 days, ACRV insiders filed 0 purchases totalling $0 and 2 sales totalling $3K — net SELLING of $3K. Most recent filing: Aug 6, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.